Topic: Mary Anne Rhyne

British drugmaker GlaxoSmithKline PLC is restructuring its U.S. operations, starting with reducing its U.S. sales force by 1,000, following many of its top competitors in eliminating sales jobs.The world's No. 2 drugmaker by revenue also will switch ...